Concurrent therapy not necessary for breast cancer patients with HER-2, study says
Wednesday, November 13, 2013 - 13:31
in Health & Medicine
Giving trastuzumab and anthracyclines at the same time is effective at treating HER-2-positive breast cancer, but there is concern that this combination can be associated with an increased risk of cardiac toxicity.